title: [Hormone replacement therapy as primary prevention?].
abstract: Benefits and risks from hormone replacement therapy are discussed if prescribed before the age of 60 years or within ten years after menopause.
authors.affiliation: Kardiologisk, Nefrologisk, Endokrinologisk Afdeling H, Hillerød Hospital, Dyrehavevej 29, 3400 Hillerød. piei@regionh.dk.
authors.forename: Pia
authors.initials: P
authors.lastname: Eiken
authors.forename: Peter
authors.initials: P
authors.lastname: Vestergaard
authors.forename: Jens-Erik
authors.initials: JE
authors.lastname: Jensen
mesh_terms: D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000517:prevention & control; D005260:Female; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause / Q000187:drug effects; D011322:Primary Prevention; D012307:Risk Factors; D020521:Stroke / Q000139:chemically induced